CLINICAL STUDY: ELECTROPHYSIOLOGY
The impairment of health-related quality of life in patients with intermittent atrial fibrillation: implications for the assessment of investigational therapy
Paul Dorian, MD*,
Werner Jung, MD ,
David Newman, MD, FACC*,
Miney Paquette, MSc*,
Kathryn Wood, PhD ,
Gregory M. Ayers, MD, PhD ,
John Camm, MD||,
Masood Akhtar, MD, FACC¶ and
Berndt Luderitz, MD
* St. Michael’s Hospital, Toronto, Ontario, Canada
University of Bonn Hospital, Bonn, Germany
Medtronic Inc., Minneapolis, Minnesota, USA
Corvascular Inc., Palo Alto, California, USA
|| St. George’s Medical School, London, England, United Kingdom
¶ St. Luke’s Hospital, Milwaukee, Wisconsin, USA
Manuscript received February 3, 1999;
revised manuscript received March 27, 2000,
accepted June 1, 2000.
Reprint requests and correspondence: Dr. David Newman, St. Michael’s Hospital, 30 Bond Street, Rm. 7-051 Queen, Toronto, Ontario, Canada, M5B 1W8
newmand{at}smh.toronto.on.ca
OBJECTIVES
We sought to assess the impact of intermittent atrial fibrillation (AF) on health-related quality of life (QoL).
BACKGROUND
Intermittent AF is a common condition with little data on health-related QoL questionnaires to guide investigational therapies.
METHODS
Outpatients from four centers, with documented AF (n = 152), completed validated QoL questionnaires (Medical Outcomes Study Short Form 36 [SF-36], Specific Activity, Symptom Checklist, Illness Intrusiveness and University of Toronto AF Severity Scales). Comparison groups were made up of healthy individuals (n = 47) and four cardiac control groups: published (n = 78) and created for study (n = 69) percutaneous transluminal coronary angioplasty (PTCA); published heart failure (n = 216) and published post-myocardial infarction (MI) (n = 107).
RESULTS
Across all domains of the SF-36, AF patients reported substantially worse QoL than healthy controls (1.3 to 2.0 standard deviation units), with scores of 24%, 23%, 16% and 30% lower than healthy individuals on measures of physical and social functioning, mental and general health, respectively (all p < 0.001). Patients with AF were either significantly worse (p < 0.05, published controls) or as impaired (study controls) as either PTCA or post-MI patients on all domains of the SF-36 and the same as heart failure controls on SF-36 psychological subscales. Patients with AF were as impaired or worse than study PTCA controls on measures of illness intrusiveness, activity limitations and symptoms. Associations between objective disease indexes and subjective QoL measures had poor correlations and accounted for <6% of the total variability in QoL scores.
CONCLUSIONS
Quality of life is as impaired in patients with intermittent AF as in patients with significant structural heart disease. Patients’ perception of QoL is not dependent on the objective measures of disease severity that are usually employed.
|
Abbreviations and Acronyms
| | AF | = atrial fibrillation | | AV | = atrioventricular | | MI | = myocardial infarction | | NYHA | = New York Heart Association functional classification | | PTCA | = percutaneous transluminal coronary angioplasty | | QoL | = quality of life | | SAS | = Goldman Specific Activity Scale | | SD | = standard deviation | | SF-36 | = Medical Outcomes Study Short Form 36 |
|
This article has been cited by other articles:
|
|
|
|
 
A. M. Gillis, M. Morck, D. V. Exner, R. S. Sheldon, H. J. Duff, B. L. Mitchell, and G. D. Wyse
Impact of atrial antitachycardia pacing and atrial pace prevention therapies on atrial fibrillation burden over long-term follow-up
Europace,
August 1, 2009;
11(8):
1041 - 1047.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Dorian, P. G. Guerra, C. R. Kerr, S. S. O'Donnell, E. Crystal, A. M. Gillis, L. B. Mitchell, D. Roy, A. C. Skanes, M. S. Rose, et al.
Validation of a New Simple Scale to Measure Symptoms in Atrial Fibrillation: The Canadian Cardiovascular Society Severity in Atrial Fibrillation Scale
Circ Arrhythm Electrophysiol,
June 1, 2009;
2(3):
218 - 224.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Jais, B. Cauchemez, L. Macle, E. Daoud, P. Khairy, R. Subbiah, M. Hocini, F. Extramiana, F. Sacher, P. Bordachar, et al.
Catheter Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation: The A4 Study
Circulation,
December 9, 2008;
118(24):
2498 - 2505.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. J. Camm and J. A. Reiffel
Defining endpoints in clinical trials on atrial fibrillation
Eur. Heart J. Suppl.,
September 1, 2008;
10(suppl_H):
H55 - H78.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
Y.-M. Cha, P. A. Friedman, S. J. Asirvatham, W.-K. Shen, T. M. Munger, R. F. Rea, P. A. Brady, A. Jahangir, K. H. Monahan, D. O. Hodge, et al.
Catheter Ablation for Atrial Fibrillation in Patients With Obesity
Circulation,
May 20, 2008;
117(20):
2583 - 2590.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. Johansson, B. Houltz, E. Berglin, G. Brandrup-Wognsen, T. Karlsson, and N. Edvardsson
Short-term sinus rhythm predicts long-term sinus rhythm and clinical improvement after intraoperative ablation of atrial fibrillation
Europace,
May 1, 2008;
10(5):
610 - 617.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. Thrall, G. Y. H. Lip, D. Carroll, and D. Lane
Depression, Anxiety, and Quality of Life in Patients With Atrial Fibrillation
Chest,
October 1, 2007;
132(4):
1259 - 1264.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A Nergardh and M Frick
Perceived heart rhythm in relation to ECG findings after direct current cardioversion of atrial fibrillation
Heart,
September 1, 2006;
92(9):
1244 - 1247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. H. Falk
Atrial Fibrillation or Sinus Rhythm?: Controversy and Contradiction in Quality of Life Outcomes
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
731 - 733.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. N. Singh, X. C. Tang, B. N. Singh, P. Dorian, D. J. Reda, C. L. Harris, R. D. Fletcher, S. C. Sharma, J. E. Atwood, A. K. Jacobson, et al.
Quality of Life and Exercise Performance in Patients in Sinus Rhythm Versus Persistent Atrial Fibrillation: A Veterans Affairs Cooperative Studies Program Substudy
J. Am. Coll. Cardiol.,
August 15, 2006;
48(4):
721 - 730.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Forlani, R. De Paulis, L. G. Wolf, R. Greco, P. Polisca, M. Moscarelli, and L. Chiariello
Conversion to Sinus Rhythm by Ablation Improves Quality of Life in Patients Submitted to Mitral Valve Surgery
Ann. Thorac. Surg.,
March 1, 2006;
81(3):
863 - 867.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. P. Gerstenfeld
Does Rhythm Control Improve Functional Status in Patients With Atrial Fibrillation?
J. Am. Coll. Cardiol.,
November 15, 2005;
46(10):
1900 - 1901.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Rienstra, D. J. Van Veldhuisen, V. E. Hagens, A. V. Ranchor, N. J.G.M. Veeger, H. J.G.M. Crijns, I. C. Van Gelder, and for the RACE Investigators
Gender-Related Differences in Rhythm Control Treatment in Persistent Atrial Fibrillation: Data of the Rate Control Versus Electrical Cardioversion (RACE) Study
J. Am. Coll. Cardiol.,
October 4, 2005;
46(7):
1298 - 1306.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. N. Singh, S. N. Singh, D. J. Reda, X. C. Tang, B. Lopez, C. L. Harris, R. D. Fletcher, S. C. Sharma, J. E. Atwood, A. K. Jacobson, et al.
Amiodarone versus Sotalol for Atrial Fibrillation
N. Engl. J. Med.,
May 5, 2005;
352(18):
1861 - 1872.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. N. Singh
Pursuit of Sinus Rhythm in Patients with Atrial Fibrillation: Is the Effort Worth It?
Journal of Cardiovascular Pharmacology and Therapeutics,
October 1, 2004;
9(4):
219 - 221.
[PDF]
|
|
|
|
|
|
|
P. Dorian, I. Mangat, A. Pinter, and V. Korley
The Burden of Atrial Fibrillation: Should We Abandon Antiarrhythmic Drug Therapy?
Journal of Cardiovascular Pharmacology and Therapeutics,
October 1, 2004;
9(4):
257 - 262.
[Abstract]
[PDF]
|
|
|
|
|
|
|
K. H. Humphries, C. R. Kerr, M. Steinbuch, P. Dorian, and for The Canadian Registry of Atrial Fibrillation
Limitations to antiarrhythmic drug use in patients with atrial fibrillation
Can. Med. Assoc. J.,
September 28, 2004;
171(7):
741 - 745.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. E. Hagens, A. V. Ranchor, E. Van Sonderen, H. A. Bosker, O. Kamp, J. G. P. Tijssen, J. H. Kingma, H. J. G. M. Crijns, I. C. Van Gelder, and the RACE Study Group
Effect of rate or rhythm control on quality of life in persistent atrial fibrillation: Results from the Rate Control Versus Electrical Cardioversion (RACE) study
J. Am. Coll. Cardiol.,
January 21, 2004;
43(2):
241 - 247.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G.C. Gronefeld and S.H. Hohnloser
Quality of life in atrial fibrillation: an increasingly important issue
Eur. Heart J. Suppl.,
September 1, 2003;
5(suppl_H):
H25 - H33.
[Abstract]
[PDF]
|
|
|
|
|
|
|
M. D.M Engelmann and S. Pehrson
Quality of life in nonpharmacologic treatment of atrial fibrillation
Eur. Heart J.,
August 1, 2003;
24(15):
1387 - 1400.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
G. C. Gronefeld, J. Lilienthal, K.-H. Kuck, S. H. Hohnloser, and for the Pharmacological Intervention in Atrial Fib
Impact of rate versus rhythm control on quality of life in patients with persistent atrial fibrillation: Results from a prospective randomized study
Eur. Heart J.,
August 1, 2003;
24(15):
1430 - 1436.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Kale and D. H. Bennett
Pacemaker prevention therapies for the control of drug-refractory paroxysmal atrial fibrillation
Europace,
January 1, 2003;
5(2):
123 - 131.
[Abstract]
[PDF]
|
|
|
|
|
|
|
R. H. Falk
Atrial Fibrillation
N. Engl. J. Med.,
April 5, 2001;
344(14):
1067 - 1078.
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. Lewalter and B. Luderitz
Quality of life in atrial fibrillation: relevance of the autonomic nervous system
Eur. Heart J.,
February 1, 2001;
22(3):
196 - 197.
[PDF]
|
|
|
|
